Joensuu, Kuopio, Eastern Finland– A recent study from the University of Eastern Finland shows that previous traumatic brain injury may potentially affect...
Amsterdam – The Journal of Parkinson’s Disease and its publisher IOS Press are proud to announce the two articles that have won the 2022 Parkinson Prize. The...
Irvine, CA, USA – When the U.S. Food and Drug Administration gave controversial accelerated approval to the first Alzheimer’s drug in nearly 20 years, it had a...
Amsterdam, NL – Last year, the FDA gave accelerated approval of the antibody aducanumab (marketed as Aduhelm by Biogen) for the treatment of Alzheimer’s disease...
Investigators found that a surprisingly large proportion of some infants with four copies of the SMN2 gene, whose families decided to postpone treatment, showed...
Madrid, Spain– Stigma, depressive symptoms and feelings of hopelessness are common problems in the early stages of Alzheimer's disease (AD). A recent study...
IOS Press would like to recognize Sudhir Srivastava's outstanding achievement as the 2022 recipient of the Don Listwin Award for Outstanding Contribution to...
Doha, Qatar – New research from Qatar University College of Health Sciences (QU-CHS) and the School of Nursing at the University of Pennsylvania has found that...
Amsterdam, NL – The Journal of Parkinson’s Disease (JPD), published by IOS Press, is pleased to announce that beginning in January 2023, JPD will transition to...
Michigan, USA –Long-term “study of studies” in Latino and non-Latino older adults shows clear hypertension link, but mystery still remains about why dementia...
